Literature DB >> 8236071

Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease.

D D Marciniuk1, R E Watts, C G Gallagher.   

Abstract

BACKGROUND: Exercise testing has become an important tool in the diagnosis and treatment of restrictive lung disease. The reproducibility of variables measured during exercise testing was examined in subjects with stable restrictive lung disease.
METHODS: Six subjects, who had never previously undergone exercise testing, each underwent three maximal incremental exercise studies on a bicycle ergometer conducted during a 28 day period.
RESULTS: Data collected at rest, before exercise, were not significantly different during the three study days. Comparison of results at the end of the exercise tests from the three studies also revealed no evidence of a significant learning effect. Reproducibility of exercise performance by subjects was assessed by the coefficient of variation. The mean within subject coefficient of variation at the end of the exercise tests was 5.6% for work rate, 7.9% for exercise duration, and 9.5% for dyspnoea. The mean within subject coefficient of variation obtained at the end of the exercise tests was 5.3% for oxygen uptake (VO2), 2.5% for oxygen saturation (SaO2), 4.0% for heart rate (HR), 5.5% for minute ventilation (VE), 5.8% for respiratory frequency (f), and 4.6% for tidal volume (VT). The mean within subject coefficient of variation at 40% and 70% of maximal work rates for VO2 was 5.7% and 5.6% respectively, for SaO2 1.3% and 1.5%, for HR 4.8% and 4.0%, for VE 6.3% and 6.6%, for f 10.1% and 7.8%, and for VT 6.0% and 4.5%.
CONCLUSIONS: Variables measured during clinical exercise testing in subjects with restrictive lung disease are highly reproducible. No significant learning effect was found on repeated testing in subjects who had never previously undergone exercise testing.

Entities:  

Mesh:

Year:  1993        PMID: 8236071      PMCID: PMC464773          DOI: 10.1136/thx.48.9.894

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

1.  Clinical usefulness of the single-breath pulmonucy diffusing capacity test.

Authors:  B BURROWS; J E KASIK; A H NIDEN; W R BARCLAY
Journal:  Am Rev Respir Dis       Date:  1961-12

2.  Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure. The need for a preliminary test.

Authors:  J S Elborn; C F Stanford; D P Nicholls
Journal:  Eur Heart J       Date:  1990-01       Impact factor: 29.983

3.  Variability of the perceived sense of effort in breathing during exercise in patients with chronic obstructive pulmonary disease.

Authors:  M Silverman; J Barry; H Hellerstein; J Janos; S Kelsen
Journal:  Am Rev Respir Dis       Date:  1988-01

4.  Reproducibility of incremental maximal cycle ergometer tests in patients with mild to moderate obstructive lung diseases.

Authors:  N J Cox; J C Hendriks; R A Binkhorst; H T Folgering; C L van Herwaarden
Journal:  Lung       Date:  1989       Impact factor: 2.584

5.  Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-11

6.  Long-term reproducibility of respiratory gas exchange measurements during exercise in patients with stable cardiac failure.

Authors:  J S Janicki; S Gupta; S T Ferris; P A McElroy
Journal:  Chest       Date:  1990-01       Impact factor: 9.410

7.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

8.  Importance of the lower respiratory tract in oxygen transfer. Exercise testing in patients with interstitial and destructive lung disease.

Authors:  B A Keogh; E Lakatos; D Price; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1984-02

9.  Variability of breathlessness measurement in patients with chronic obstructive pulmonary disease.

Authors:  M J Belman; L R Brooks; D J Ross; Z Mohsenifar
Journal:  Chest       Date:  1991-03       Impact factor: 9.410

10.  Determination of severe impairment (disability) in interstitial lung disease.

Authors:  G R Epler; F A Saber; E A Gaensler
Journal:  Am Rev Respir Dis       Date:  1980-04
View more
  2 in total

1.  Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment.

Authors:  Betsy A Keller; John Luke Pryor; Ludovic Giloteaux
Journal:  J Transl Med       Date:  2014-04-23       Impact factor: 5.531

2.  Feasibility of cardiopulmonary exercise testing in interstitial lung disease: the PETFIB study.

Authors:  Owen Tomlinson; Anna Duckworth; Laura Markham; Rebecca Wollerton; Bridget Knight; Alexander Spiers; Michael Gibbons; Craig Williams; Chris Scotton
Journal:  BMJ Open Respir Res       Date:  2021-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.